LIFE-ME: Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology.

Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic
Sensor Technology.

10.02.2020, Oslo

Lifecare AS, a Norwegian life-science company, announced that they have filed
for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology.

The purpose of this clinical pilot study is to explore the performance of the
Sencell sensor technology in measuring interstitial glucose by means of an
osmotic pressure sensing cell during a standardized meal test in healthy
subjects.
  
The Clinical Study Protocol is filed with the Ethics-Committee (Institutional
Review Board (IRB)) and the regulatory authorities in parallel for approval of
the human trial. This is a significant advancement in the development of the
solutions to address the diabetes epidemic. The first study in humans is the
next phase of the technology development and it enables the company to generate
human data, earlier than expected, with the groundbreaking technology. 

“This is another step towards miniaturizing the Sencell Glucose Sensor,” says Dr
Andreas Pfützner, CSO, Lifecare. “The sensor has now been developed to a point
where it is already smaller than the initial targeted size. This also allows the
sensing element to be put into a hypodermic needle for early tests in human
subjects.” 

Lifecare is developing an implantable continuous glucose sensor based on its
proprietary osmotic pressure cell technology to provide fast and reliable
measurements of the glucose information required for acute, chronic or routine
medical care. The news about the upcoming tests comes after Lifecare announced
in Q-2 2019 that its nanosensor based technology has been shown in laboratory
experiments to accurately measure pressure changes derived from substantially
smaller osmotic pressure chambers than previously available. 

For more information please contact: 
Dr Andreas Pfützner 
Chief Scientific Officer, Lifecare
+ 45 172 6296117 
andreas.pfuetzner@sciema.de 

Rune Frisvold
Chief Operating Officer, Lifecare
+47 90136063
rune.frisvold@lifecare.no